KARL STORZ completes acquisition of Asensus Surgical, Inc. to strengthen its position in robotic and digital surgical market
Acquiring Company
KARL STORZ
Acquired Company
Asensus Surgical
Description
Asensus Surgical, Inc. (NYSE American: ASXC) has announced the closing of the merger with the KARL STORZ Group. Under the terms of the merger agreement, KARL STORZ Endoscopy-America, Inc., a wholly owned direct subsidiary of KARL STORZ, has acquired all outstanding shares of Asensus Surgical for $0.35 per share in cash, making Asensus Surgical a subsidiary of KARL STORZ.
Who to call at KARL STORZ, and when
When KARL STORZ changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day KARL STORZ raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KARL STORZ, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KARL STORZ. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KARL STORZ makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Asensus Surgical?
Asensus Surgical was acquired by KARL STORZ, based in Baden-Württemberg. The deal was reported on August 22, 2024. KARL STORZ is a leading family-owned medical technology company focused on endoscopic technology and imaging solutions across various surgical specialties. KARL STORZ is privately held and operates in Information Technology.
When did KARL STORZ acquire Asensus Surgical?
KARL STORZ's acquisition of Asensus Surgical was reported on August 22, 2024. Asensus Surgical, Inc. (NYSE American: ASXC) has announced the closing of the merger with the KARL STORZ Group. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Asensus Surgical do?
Asensus Surgical, Inc. is a medical device company focused on digitizing the interface between the surgeon and the patient. It is privately held, operating in Biotechnology, and is based in Durham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.